These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 10579796)

  • 1. Tumor angiogenesis is associated with progression after radical prostatectomy in pT2/pT3 prostate cancer.
    Strohmeyer D; Rössing C; Strauss F; Bauerfeind A; Kaufmann O; Loening S
    Prostate; 2000 Jan; 42(1):26-33. PubMed ID: 10579796
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic aberrations in prostate carcinoma detected by comparative genomic hybridization and microsatellite analysis: association with progression and angiogenesis.
    Strohmeyer DM; Berger AP; Moore DH; Bartsch G; Klocker H; Carroll PR; Loening SA; Jensen RH
    Prostate; 2004 Apr; 59(1):43-58. PubMed ID: 14991865
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor angiogenesis correlates with progression after radical prostatectomy but not with pathologic stage in Gleason sum 5 to 7 adenocarcinoma of the prostate.
    Silberman MA; Partin AW; Veltri RW; Epstein JI
    Cancer; 1997 Feb; 79(4):772-9. PubMed ID: 9024715
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of microvessel density in prostate cancer: a tissue microarray study.
    Erbersdobler A; Isbarn H; Dix K; Steiner I; Schlomm T; Mirlacher M; Sauter G; Haese A
    World J Urol; 2010 Dec; 28(6):687-92. PubMed ID: 19714336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microvessel density in prostate cancer: lack of correlation with tumor grade, pathologic stage, and clinical outcome.
    Rubin MA; Buyyounouski M; Bagiella E; Sharir S; Neugut A; Benson M; de la Taille A; Katz AE; Olsson CA; Ennis RD
    Urology; 1999 Mar; 53(3):542-7. PubMed ID: 10096381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of bFGF, VEGF and c-met and their correlation with microvessel density and progression in prostate carcinoma.
    Strohmeyer D; Strauss F; Rössing C; Roberts C; Kaufmann O; Bartsch G; Effert P
    Anticancer Res; 2004; 24(3a):1797-804. PubMed ID: 15274358
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contrast-enhanced transrectal color doppler ultrasonography (TRCDUS) for assessment of angiogenesis in prostate cancer.
    Strohmeyer D; Frauscher F; Klauser A; Recheis W; Eibl G; Horninger W; Steiner H; Volgger H; Bartsch G
    Anticancer Res; 2001; 21(4B):2907-13. PubMed ID: 11712785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression of biomarkers modulating prostate cancer progression: implications in the treatment of the disease.
    Di Lorenzo G; De Placido S; Autorino R; De Laurentiis M; Mignogna C; D'Armiento M; Tortora G; De Rosa G; D'Armiento M; De Sio M; Bianco AR; D'Armiento FP
    Prostate Cancer Prostatic Dis; 2005; 8(1):54-9. PubMed ID: 15655565
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thrombospondin-1 expression in patients with pathologic stage T3 prostate cancer undergoing radical prostatectomy: association with p53 alterations, tumor angiogenesis, and tumor progression.
    Grossfeld GD; Carroll PR; Lindeman N; Meng M; Groshen S; Feng AC; Hawes D; Cote RJ
    Urology; 2002 Jan; 59(1):97-102. PubMed ID: 11796289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microvessel density in prostate carcinoma.
    Bono AV; Celato N; Cova V; Salvadore M; Chinetti S; Novario R
    Prostate Cancer Prostatic Dis; 2002; 5(2):123-7. PubMed ID: 12497001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor angiogenesis as an independent prognostic factor after extended radical esophagectomy for invasive squamous cell carcinoma of the esophagus.
    Nakagawa S; Nishimaki T; Suzuki T; Kanda T; Kuwabara S; Hatakeyama K
    Surgery; 2001 Mar; 129(3):302-8. PubMed ID: 11231458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relation of microvessel density with microvascular invasion, metastasis and prognosis in renal cell carcinoma.
    Yildiz E; Ayan S; Goze F; Gokce G; Gultekin EY
    BJU Int; 2008 Mar; 101(6):758-64. PubMed ID: 18070177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Independent prognostic importance of microvessel density in clinically localized prostate cancer.
    Halvorsen OJ; Haukaas S; Høisaeter PA; Akslen LA
    Anticancer Res; 2000; 20(5C):3791-9. PubMed ID: 11268456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Microvessel density, p53, retinoblastoma, and chromogranin A immunohistochemistry as predictors of disease-specific survival following radical prostatectomy for carcinoma of the prostate.
    Krupski T; Petroni GR; Frierson HF; Theodorescu JU
    Urology; 2000 May; 55(5):743-9. PubMed ID: 10792093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular endothelial growth factor and its correlation with angiogenesis and p53 expression in prostate cancer.
    Strohmeyer D; Rössing C; Bauerfeind A; Kaufmann O; Schlechte H; Bartsch G; Loening S
    Prostate; 2000 Nov; 45(3):216-24. PubMed ID: 11074523
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Angiogenesis: prognostic marker in prostatic cancer].
    Borre M; Offersen IB; Nerstrøm B; Overgaard J
    Ugeskr Laeger; 1999 Jun; 161(25):3832-6. PubMed ID: 10412301
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative microvessel density. A staging and prognostic marker for human prostatic carcinoma.
    Brawer MK
    Cancer; 1996 Jul; 78(2):345-9. PubMed ID: 8674015
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the prognostic potential of hyaluronic acid, hyaluronidase (HYAL-1), CD44v6 and microvessel density for prostate cancer.
    Ekici S; Cerwinka WH; Duncan R; Gomez P; Civantos F; Soloway MS; Lokeshwar VB
    Int J Cancer; 2004 Oct; 112(1):121-9. PubMed ID: 15305383
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis, p53, bcl-2 and Ki-67 in the progression of prostate cancer after radical prostatectomy.
    Moul JW
    Eur Urol; 1999; 35(5-6):399-407. PubMed ID: 10325496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor angiogenesis is associated with MUC1 overexpression and loss of prostate-specific antigen expression in prostate cancer.
    Papadopoulos I; Sivridis E; Giatromanolaki A; Koukourakis MI
    Clin Cancer Res; 2001 Jun; 7(6):1533-8. PubMed ID: 11410487
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.